Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Dreger, P (author)

Michallet, M (author)

Bosman, P (author)

show more...

Dietrich, S (author)

Sobh, M (author)

Boumendil, A (author)

Nagler, A (author)

Scheid, C (author)

Cornelissen, J (author)

Niederwieser, D (author)

Muller, L (author)

Vandenberghe, E (author)

Scortechini, I (author)

Schoemans, H (author)

Andersen, NS (author)

Finke, J (author)

Russo, D (author)

Ljungman, P (author)

Karolinska Institutet

Passweg, J (author)

van Gelder, M (author)

Durakovic, N (author)

Labussiere-Wallet, H (author)

Berg, T (author)

Wulf, G (author)

Bethge, W (author)

Bunjes, D (author)

Stilgenbauer, S (author)

Canepari, ME (author)

Schaap, M (author)

Fox, CP (author)

Kroger, N (author)

Montoto, S (author)

Schetelig, J (author)

show less...

 (creator_code:org_t)

2018-05-04

2019

English.

In: Bone marrow transplantation. - : Springer Science and Business Media LLC. - 1476-5365 .- 0268-3369. ; 54:1, s. 44-52

Related links:

https://www.nature.c...

show more...

http://kipublication...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)